Cargando…

Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma

Inflammatory response plays a crucial role in the development and progression of gliomas. Whereas the prognostic esteem of inflammatory response-related genes has never been comprehensively explored in glioma, the RNA-seq information and clinical data of patients with glioma were extracted from TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhen, Zheng, Baoping, Zheng, Jianglin, Zhang, Yi, Jiang, Cheng, Nie, Chuansheng, Jiang, Xiaobing, Yao, Dongxiao, Zhao, Hongyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516783/ https://www.ncbi.nlm.nih.gov/pubmed/37488455 http://dx.doi.org/10.1007/s12031-023-02142-x

Ejemplares similares

A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme
por: Xiao, Dongdong, et al.
Publicado: (2021)

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
por: Jiang, Cheng, et al.
Publicado: (2023)

RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma
por: Xiao, Dongdong, et al.
Publicado: (2022)

An integrative multi-omics analysis based on liquid–liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature
por: Zheng, Jianglin, et al.
Publicado: (2022)

Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience
por: Nie, Chuansheng, et al.
Publicado: (2022)

Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m(6)A-dependent recognition of Nrf2 mRNA mediated by SND1
por: Zheng, Jianglin, et al.
Publicado: (2023)

Comparison of Microvascular Decompression and Two Isocenters Gamma Knife for the Treatment of Trigeminal Neuralgia Caused by Vertebrobasilar Dolichoectasia
por: Zhao, Zhen, et al.
Publicado: (2021)

Development of a Nomogram Based on Preoperative Bi-Parametric MRI and Blood Indices for the Differentiation Between Cystic-Solid Pituitary Adenoma and Craniopharyngioma
por: Zhao, Zhen, et al.
Publicado: (2021)

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas
por: Han, Mingzhi, et al.
Publicado: (2022)

Surgical management of tuberculum sellae meningioma: Transcranial approach or endoscopic endonasal approach?
por: Qian, Kang, et al.
Publicado: (2022)

Integrative Analysis of the Predictive Value of Perilipin Family on Clinical Significance, Prognosis and Immunotherapy of Glioma
por: Li, Xuanxuan, et al.
Publicado: (2023)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas
por: Zhao, Wei-jiang, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma
por: Xia, Qin-Xuan, et al.
Publicado: (2022)

Immune‐related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients
por: Yu, Hao, et al.
Publicado: (2022)

Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021)

A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2022)

Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
por: Wu, Yangyang, et al.
Publicado: (2023)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

Identification of Critical m(6)A RNA Methylation Regulators with Prognostic Value in Lower-Grade Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma
por: Zong, Wei-Feng, et al.
Publicado: (2022)

Identification of a Novel Gene Signature Based on Kinesin Family Members to Predict Prognosis in Glioma
por: Pan, Dongxiao, et al.
Publicado: (2023)

Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
por: Jiang, Feng, et al.
Publicado: (2022)

Mutational profiling of low‐grade gliomas identifies prognosis and immunotherapy‐related biomarkers and tumour immune microenvironment characteristics
por: Lin, Wen‐wen, et al.
Publicado: (2021)

TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion
por: Zhang, Qing, et al.
Publicado: (2023)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
por: Fan, Wenhua, et al.
Publicado: (2022)

High PYGL Expression Predicts Poor Prognosis in Human Gliomas
por: Zhao, Chang-yi, et al.
Publicado: (2021)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
por: Jiang, Yuan, et al.
Publicado: (2022)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2022)

Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas
por: Wang, Chengcheng, et al.
Publicado: (2023)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

Remodelling and Treatment of the Blood-Brain Barrier in Glioma
por: Wang, Yihao, et al.
Publicado: (2021)

Predicting the prognosis of glioma by pyroptosis‐related signature
por: Chao, Bo, et al.
Publicado: (2021)

Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s7pjag9slobe4j3d7lpfd5ca63